Source:

Healio Interview

Disclosures: Stefanski reports no relevant financial disclosures.
May 13, 2022
1 min watch
Save

Umbilical cord blood an appropriate stem cell source for certain patients

Source:

Healio Interview

Disclosures: Stefanski reports no relevant financial disclosures.
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

In the second installment of a three-part video series, Heather Stefanski, MD, PhD, discusses the potential role of umbilical cord blood as a stem cell source.

“Ethnically diverse patients are appropriate candidates for umbilical cord blood because they don’t have to be perfectly matched, and the chance of getting graft-versus-host disease is less with umbilical cord blood,” Stefanski — vice president of medical services for National Marrow Donor Program/Be The Match — told Healio.

Stefanski also shares the reasons why she used umbilical cord blood when she was treating patients with leukemia, as well as related guidelines developed by National Marrow Donor Program/Be The Match and Center for International Blood and Marrow Transplant Research.

Click here to see the first installment of the video series in which Stefanski highlights the lack of equality in access to potentially lifesaving transplant based on ethnicity and recent research efforts designed to mitigate the impact of HLA mismatches.